Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
July 07, 2023 at 13:59 PM EDT
Analysts believe the Medicare registry requirement and new guidance on Leqembi's prescription label could potentially weigh on sales in the near term.